GSK
GlaxoSmithKline PLC ADR
NYSE: GSK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$52.31
+1.77% today
Updated 2026-04-30
Market cap
$104.41B
P/E ratio
13.62
P/S ratio
3.19x
EPS (TTM)
$3.84
Dividend yield
3.44%
52W range
$34 – $61
Volume
4.7M
GlaxoSmithKline PLC ADR (GSK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
17.80%
Operating margin
36.30%
ROE
40.90%
ROA
10.00%
Debt/equity
1.10x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $23.22B | $5.39B | 78.43% | 33.62% | 23.20% |
| 2007 | $22.74B | $5.22B | 77.08% | 34.91% | 22.95% |
| 2008 | $24.35B | $4.60B | 73.66% | 29.32% | 18.90% |
| 2009 | $28.37B | $5.53B | 73.98% | 29.70% | 19.50% |
| 2010 | $28.39B | $1.63B | 72.18% | 13.32% | 5.76% |
| 2011 | $27.39B | $5.26B | 72.07% | 28.51% | 19.21% |
| 2012 | $26.43B | $4.50B | 70.02% | 27.62% | 17.02% |
| 2013 | $26.50B | $5.44B | 67.61% | 26.52% | 20.51% |
| 2014 | $23.01B | $2.76B | 68.17% | 15.64% | 11.98% |
| 2015 | $23.92B | $8.42B | 62.99% | 43.15% | 35.20% |
| 2016 | $27.89B | $912.00M | 66.69% | 9.32% | 3.27% |
| 2017 | $30.19B | $1.53B | 65.74% | 13.54% | 5.08% |
| 2018 | $30.82B | $3.62B | 66.77% | 17.79% | 11.75% |
| 2019 | $33.75B | $4.64B | 64.85% | 20.62% | 13.76% |
| 2020 | $24.35B | $5.75B | 67.44% | 24.55% | 23.61% |
| 2021 | $24.70B | $4.38B | 66.95% | 17.64% | 17.76% |
| 2022 | $29.32B | $14.96B | 67.42% | 21.94% | 51.00% |
| 2023 | $30.33B | $4.93B | 71.76% | 22.24% | 16.25% |
| 2024 | $31.38B | $2.58B | 71.16% | 12.82% | 8.21% |
| 2025 | $31.95B | $5.59B | 72.54% | 21.95% | 17.50% |